115
Participants
Start Date
January 10, 2018
Primary Completion Date
July 8, 2020
Study Completion Date
August 31, 2022
OBE022
Oral
Placebos
Oral
Atosiban
I.V.
Gynekologicko-porodnická klinika Fakultní nemocnice Brno, Brno
Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze, Prague
Ústav pro péči o matku a dítě, Prague
Helsinki Universisty Hospital, Helsinki
Hilel Yafe Medical Center, Maternal Fetal Unit, Haifa
Rambam Medical Center, Maternal Fetal Unit, Haifa
Meir Medical Center, Obstetrics and Gynecology Department, Kfar Saba
Rabin Medical Center, Fetal-Maternal Medicine, Helen Schneider's Hospital for Women, Petah Tikva
Moscow Regional Perinatal Center, Balashikha
Kazan State Medical University, Kazan'
City clinical hospital № 15 named after O. M. Filatov of Healthcare Department of Moscow, Moscow
Perinatal center of the City Clinical Hospital #24, Moscow
Hospital La Paz, Madrid
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia
Hospital Clínico Universitario de Santiago, Santiago de Compostela
Hospital Universitari i Politècnic La Fe, Valencia
Hanoi Obstetrics and Gynecology Hospital, Hanoi
My Duc Hospital, Ho Chi Minh City
Lead Sponsor
Collaborators (1)
Scope International AG
INDUSTRY
Iqvia Pty Ltd
INDUSTRY
Cytel Inc.
INDUSTRY
PhinC Development
INDUSTRY
ObsEva SA
INDUSTRY